- Zimlovisertib and tofacitinib combo effective in treating rheumatoid arthritis: Study 05/06/2025 22:05 Medical Dialogues A new study published in the journal of Arthritis and Rheumatology showed that the combination of zimlovisertib and tofacitinib shows promise in the treatment of rheumatoid arthritis. Pain, stiffness, swelling, and eventually joint destruction are the main …
- Belimumab Superior to Placebo in Systemic Lupus Erythematosus Treatment: Study 05/06/2025 22:05 Medical Dialogues Researchers have found in a recent meta-analysis that belimumab is more effective than placebo in treating systemic lupus erythematosus (SLE), based on BICLA criteria. This finding reinforces belimumab's clinical utility and may help guide future …
- Rheumatology Month in Review: May 2025 05/06/2025 19:23 HCPLive In May, the rheumatology landscape was marked by key clinical trial readouts, expanded efficacy data for approved therapies, and new insights into disease burden and management strategies. Notably, Merck KGaA reported positive phase 2 results for enpatoran …
- Obinutuzumab Reduces Urinary Biomarkers of Lupus in Phase 2 NOBILITY Analysis 05/06/2025 19:23 HCPLive A secondary analysis of the NOBILITY trial is offering clinicians further insight into the safety and efficacy of obinutuzumab (Gazya/Gazyvaro) among patients with lupus nephritis (LN). The posthoc analysis, which was presented at the 62nd European …
- Dentons helps The Arthritis Movement launch Clara app 05/06/2025 19:23 ICLG The app seeks to make life easier for Australians living with arthritis. The app seeks to make life easier for Australians living with arthritis. Global law firm Dentons has advised non-profit organisation The Arthritis Movement on a digital companion, AI- …
- Arthritis community weekend to honor heroes and raise hope in Capital Region 05/06/2025 16:00 WRGB CBS 6 Albany - New York ALBANY, N.Y. (WRGB) — Nearly 60 million adults and hundreds of thousands of children in the United States are living with arthritis, according to the Arthritis Foundation. For those affected, movement is often considered medicine. In the Capital Region, …
- AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis 05/06/2025 12:54 Pharmabiz.com AnaptysBio, Inc., a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced that investigational rosnilimab, a depleter and agonist targeting PD-1+ T cells, demonstrated a best-in-disease profile in patients …
- ACR Releases New Guideline for Lupus Treatment 05/06/2025 12:49 Medscape The American College of Rheumatology (ACR) has released a summary of a guideline with updated recommendations for the treatment of systemic lupus erythematosus (SLE). The previous guideline for managing SLE in adults was published in 1999, said Lisa R. …
- Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 05/06/2025 11:00 EIN Presswire CHATHAM, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced a poster …
- Do Tomatoes and Nightshade Veggies Really Aggravate Arthritis Symptoms? 05/06/2025 02:04 Woman's World - New Jersey If you’re living with arthritis, you know that everyday choices—like how much you move or what you eat—can affect your pain levels. There’s also long been speculation around whether produce in the nightshade family like tomatoes, peppers, eggplant and …
Warning: Undefined variable $hide_title_text in /home/u905973774/domains/odishaarthritis.com/public_html/wp-content/themes/i-transform-child/page-sidebar.php on line 30